Key financial ranges
Market cap · USD equivalent
P/E ratio
Annual revenue · USD equivalent
Revenue growth
Valuation & profitability
Price / sales
Annual net income · USD equivalent
Net profit margin
Cash & debt
Cash · USD equivalent
Total debt · USD equivalent
Net cash · USD equivalent
Debt / revenue
| Company | Market cap | P/E | Revenue | Rev. growth | Net income | Cash | Debt | AI value |
|---|---|---|---|---|---|---|---|---|
| AMTDAmtd Idea Group | $1.47B | 1.2× | $101.22M | +25.8% | $67.25M | $51.07M | $562.33M | Undervalued |
| AMALAmalgamated Financial Corp. | $1.47B | 13.1× | $328.72M | +4.1% | $104.45M | $167.78M | $9.09M | Fair valued |
| WDWalker & Dunlop, Inc. | $1.47B | 38.3× | $319.96M | +20.6% | $56.25M | $160.86M | $105.13M | Fair valued |
| AGLagilon health, inc. | $1.48B | — | $5.93B | -2.1% | -$391.35M | $107.18M | $33.45M | Overvalued |
| XZOExzeo Group, Inc. | $1.48B | 17.5× | $216.98M | +62.0% | $82.75M | $136.73M | $6.62M | Fair valued |
| INNVInnovAge Holding Corp. | $1.48B | — | $853.7M | +11.8% | -$30.31M | $95.54M | $93.85M | Fair valued |
| GFRGreenfire Resources Ltd. | $1.48B | — | CA$584.4M | -26.1% | CA$47.5M | CA$41.97M | CA$6.11M | Fair valued |
| WOLFWolfspeed, Inc. | $1.49B | — | $468.3M | -38.2% | -$415.8M | $576.3M | $1.8B | Overvalued |
| AKTSAktis Oncology, Inc. | $1.49B | — | $1.49M | — | -$43.98M | $82.49M | $11.24M | Overvalued |
| HCSGHealthcare Services Group Inc | $1.49B | 12.6× | $1.84B | +7.1% | $59.06M | $123.41M | $17.73M | Fair valued |
| NRPNatural Resource Partners Lp | $1.49B | 14.4× | $232.35M | -16.6% | $183.64M | $30.13M | $27.36M | Fair valued |
| SDGRSchrodinger, Inc. | $1.5B | — | $255.87M | +23.3% | -$103.27M | $287.85M | $107.98M | Fair valued |
| KMTSKestra Medical Technologies, Ltd. | $1.5B | — | $95.13M | +59.0% | -$131.61M | $99.71M | $46.79M | Overvalued |
| TPBTurning Point Brands, Inc. | $1.5B | 32.3× | $463.06M | +28.4% | $58.17M | $268.31M | $294.15M | Overvalued |
| HLMNHillman Solutions Corp. | $1.5B | 37.3× | $1.55B | +5.4% | $40.31M | $35.84M | $816.8M | Undervalued |
| LYNXLyntris Inc. | $1.51B | — | $388.94M | +16.5% | -$8.46M | — | $284.7M | Fair valued |
| LKFNLakeland Financial Corp | $1.51B | 13.9× | $268.99M | +6.1% | $103.36M | $194.13M | $77.89M | Fair valued |
| ALMSAlumis Inc. | $1.51B | — | $24.05M | — | -$243.33M | $63.71M | $36.43M | Fair valued |
| SAFTSafety Insurance Group Inc | $1.51B | 22.2× | $1.26B | +12.8% | $99.26M | $67.92M | $59.77M | Fair valued |
| AVBPArriVent BioPharma, Inc. | $1.51B | — | — | — | — | $154.68M | $351K | Fair valued |